vs
Side-by-side financial comparison of N-able, Inc. (NABL) and Vericel Corp (VCEL). Click either name above to swap in a different company.
N-able, Inc. is the larger business by last-quarter revenue ($130.3M vs $92.9M, roughly 1.4× Vericel Corp). On growth, Vericel Corp posted the faster year-over-year revenue change (23.3% vs 11.8%). N-able, Inc. produced more free cash flow last quarter ($20.9M vs $12.8M). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs 7.0%).
Able UK is a British industrial services company specialising in decommissioning of ships and offshore installations.
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
NABL vs VCEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $130.3M | $92.9M |
| Net Profit | — | $23.2M |
| Gross Margin | 76.2% | 78.7% |
| Operating Margin | 10.2% | 24.1% |
| Net Margin | — | 25.0% |
| Revenue YoY | 11.8% | 23.3% |
| Net Profit YoY | — | 17.3% |
| EPS (diluted) | $-0.04 | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $130.3M | $92.9M | ||
| Q3 25 | $131.7M | $67.5M | ||
| Q2 25 | $131.2M | $63.2M | ||
| Q1 25 | $118.2M | $52.6M | ||
| Q4 24 | $116.5M | $75.4M | ||
| Q3 24 | $116.4M | $57.9M | ||
| Q2 24 | $119.4M | $52.7M | ||
| Q1 24 | $113.7M | $51.3M |
| Q4 25 | — | $23.2M | ||
| Q3 25 | $1.4M | $5.1M | ||
| Q2 25 | $-4.0M | $-553.0K | ||
| Q1 25 | $-7.2M | $-11.2M | ||
| Q4 24 | — | $19.8M | ||
| Q3 24 | $10.8M | $-901.0K | ||
| Q2 24 | $9.5M | $-4.7M | ||
| Q1 24 | $7.5M | $-3.9M |
| Q4 25 | 76.2% | 78.7% | ||
| Q3 25 | 77.5% | 73.5% | ||
| Q2 25 | 78.1% | 73.7% | ||
| Q1 25 | 76.6% | 69.0% | ||
| Q4 24 | 80.0% | 77.6% | ||
| Q3 24 | 82.9% | 71.9% | ||
| Q2 24 | 84.0% | 69.5% | ||
| Q1 24 | 83.9% | 68.9% |
| Q4 25 | 10.2% | 24.1% | ||
| Q3 25 | 8.8% | 5.1% | ||
| Q2 25 | 7.7% | -3.2% | ||
| Q1 25 | 1.5% | -24.3% | ||
| Q4 24 | 13.7% | 24.5% | ||
| Q3 24 | 20.5% | -4.3% | ||
| Q2 24 | 18.4% | -11.5% | ||
| Q1 24 | 18.0% | -10.7% |
| Q4 25 | — | 25.0% | ||
| Q3 25 | 1.1% | 7.5% | ||
| Q2 25 | -3.1% | -0.9% | ||
| Q1 25 | -6.1% | -21.4% | ||
| Q4 24 | — | 26.3% | ||
| Q3 24 | 9.2% | -1.6% | ||
| Q2 24 | 7.9% | -8.9% | ||
| Q1 24 | 6.6% | -7.5% |
| Q4 25 | $-0.04 | $0.46 | ||
| Q3 25 | $0.01 | $0.10 | ||
| Q2 25 | $-0.02 | $-0.01 | ||
| Q1 25 | $-0.04 | $-0.23 | ||
| Q4 24 | $0.01 | $0.40 | ||
| Q3 24 | $0.06 | $-0.02 | ||
| Q2 24 | $0.05 | $-0.10 | ||
| Q1 24 | $0.04 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $111.8M | $137.5M |
| Total DebtLower is stronger | $393.9M | — |
| Stockholders' EquityBook value | $804.7M | $354.6M |
| Total Assets | $1.4B | $488.0M |
| Debt / EquityLower = less leverage | 0.49× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $111.8M | $137.5M | ||
| Q3 25 | $101.4M | $135.4M | ||
| Q2 25 | $93.9M | $116.9M | ||
| Q1 25 | $94.1M | $112.9M | ||
| Q4 24 | $85.2M | $116.2M | ||
| Q3 24 | $174.4M | $101.7M | ||
| Q2 24 | $157.5M | $102.5M | ||
| Q1 24 | $139.2M | $110.6M |
| Q4 25 | $393.9M | — | ||
| Q3 25 | $331.7M | — | ||
| Q2 25 | $332.1M | — | ||
| Q1 25 | $332.6M | — | ||
| Q4 24 | $333.1M | — | ||
| Q3 24 | $333.6M | — | ||
| Q2 24 | $334.1M | — | ||
| Q1 24 | $334.5M | — |
| Q4 25 | $804.7M | $354.6M | ||
| Q3 25 | $813.4M | $321.9M | ||
| Q2 25 | $809.4M | $306.8M | ||
| Q1 25 | $775.1M | $295.5M | ||
| Q4 24 | $759.3M | $292.0M | ||
| Q3 24 | $765.0M | $257.5M | ||
| Q2 24 | $724.4M | $243.0M | ||
| Q1 24 | $709.1M | $233.9M |
| Q4 25 | $1.4B | $488.0M | ||
| Q3 25 | $1.4B | $453.3M | ||
| Q2 25 | $1.4B | $435.6M | ||
| Q1 25 | $1.4B | $424.6M | ||
| Q4 24 | $1.3B | $432.7M | ||
| Q3 24 | $1.2B | $390.4M | ||
| Q2 24 | $1.2B | $376.8M | ||
| Q1 24 | $1.1B | $356.7M |
| Q4 25 | 0.49× | — | ||
| Q3 25 | 0.41× | — | ||
| Q2 25 | 0.41× | — | ||
| Q1 25 | 0.43× | — | ||
| Q4 24 | 0.44× | — | ||
| Q3 24 | 0.44× | — | ||
| Q2 24 | 0.46× | — | ||
| Q1 24 | 0.47× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $25.3M | $15.0M |
| Free Cash FlowOCF − Capex | $20.9M | $12.8M |
| FCF MarginFCF / Revenue | 16.0% | 13.8% |
| Capex IntensityCapex / Revenue | 3.4% | 2.4% |
| Cash ConversionOCF / Net Profit | — | 0.65× |
| TTM Free Cash FlowTrailing 4 quarters | $75.1M | $24.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $25.3M | $15.0M | ||
| Q3 25 | $24.0M | $22.1M | ||
| Q2 25 | $24.2M | $8.2M | ||
| Q1 25 | $19.7M | $6.6M | ||
| Q4 24 | $26.0M | $22.2M | ||
| Q3 24 | $22.0M | $10.2M | ||
| Q2 24 | $27.3M | $18.5M | ||
| Q1 24 | $4.2M | $7.2M |
| Q4 25 | $20.9M | $12.8M | ||
| Q3 25 | $17.4M | $19.5M | ||
| Q2 25 | $20.4M | $81.0K | ||
| Q1 25 | $16.4M | $-7.6M | ||
| Q4 24 | $18.8M | $8.5M | ||
| Q3 24 | $18.2M | $-9.2M | ||
| Q2 24 | $24.0M | $1.8M | ||
| Q1 24 | $746.0K | $-6.8M |
| Q4 25 | 16.0% | 13.8% | ||
| Q3 25 | 13.2% | 28.8% | ||
| Q2 25 | 15.5% | 0.1% | ||
| Q1 25 | 13.9% | -14.5% | ||
| Q4 24 | 16.2% | 11.2% | ||
| Q3 24 | 15.7% | -15.9% | ||
| Q2 24 | 20.1% | 3.4% | ||
| Q1 24 | 0.7% | -13.3% |
| Q4 25 | 3.4% | 2.4% | ||
| Q3 25 | 5.0% | 3.9% | ||
| Q2 25 | 2.9% | 12.9% | ||
| Q1 25 | 2.8% | 27.0% | ||
| Q4 24 | 6.1% | 18.3% | ||
| Q3 24 | 3.2% | 33.5% | ||
| Q2 24 | 2.7% | 31.8% | ||
| Q1 24 | 3.0% | 27.3% |
| Q4 25 | — | 0.65× | ||
| Q3 25 | 17.36× | 4.35× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.12× | ||
| Q3 24 | 2.04× | — | ||
| Q2 24 | 2.89× | — | ||
| Q1 24 | 0.56× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NABL
| Transferred Over Time | $121.9M | 94% |
| Transferred At Point In Time | $8.4M | 6% |
| Other Revenue | $1.3M | 1% |
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
